Think Biosolution

Based in Dublin, Ireland, Think Biosolution operates as an original design manufacturer (ODM) specializing in chronic disease prevention platforms for the long-term care sector. The company was founded in March 2016 by Dr. Shourjya Sanyal (CEO) and Koushik Kumar Nundy (CTO). The founders' journey began when they were university friends in India; a personal experience with the healthcare system involving Dr. Sanyal's grandmother inspired their mission to create accessible health tracking solutions to prevent hospitalizations.

Dr. Sanyal holds a PhD from University College Dublin's School of Physics and has a background in biomedical engineering and image processing. Mr. Nundy is an electrical engineer with a master's degree in telecommunications from The Hong Kong University of Science and Technology and experience in high-tech startups. Their combined expertise in technology and science forms the foundation of the company's direction.

Think Biosolution develops both hardware and software to support assisted living and home healthcare agencies in the US and Ireland. The business model is centered on providing privately labeled wearable medical devices and customizable software platforms to telehealth brands and provider organizations. These platforms are designed for the early detection and management of chronic conditions such as hypertension, diabetes, and cardiac diseases, aiming to reduce hospitalizations and the overall cost of care. The company generates revenue through its specialized platforms, including the At-Home Geriatric Care Platform and, previously, an At-Home COVID-19 Monitoring Platform.

A key product is the QuasaR™ wearable device, a chest-worn monitor that measures a wide range of biometric data, including heart rate, respiratory rate, blood oxygen saturation, heart rate variability, blood pressure, temperature, and movement. This device, which is seeking CE-Marking and FDA 510(k) approval, transmits data to a HIPAA-compliant cloud server, where it can be viewed on a clinical dashboard by healthcare professionals. The platform integrates with Electronic Health Records (EHR) and uses disease-specific risk indicators and early warning scores to triage high-risk patients. Notably, the company has incorporated Galileo GNSS capabilities into the QuasaR™ device, intended to function as a wandering alert for dementia patients and to help locate patients during emergencies.

Keywords: chronic disease prevention, remote patient monitoring, wearable medical devices, telehealth platform, geriatric care technology, assisted living solutions, home healthcare, digital health, vital signs monitoring, QuasaR device, early warning score, clinical dashboard, healthcare ODM, patient triaging, biometric data, hypertension detection, diabetes management, cardiac monitoring, long-term care technology